pdufa.bio
HomeReadouts › December 2027

December 2027 clinical-trial readouts

Updated ยทnext FDA decision on the calendar
trial-readout estimates for December 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← November 2027
13 readouts
RARE · Dec 2027 (est.)
Triheptanoin: Medium-chain Acyl-CoA Dehydrogenase Deficiency
ANVS · Dec 2027 (est.)
buntanetap/posiphen: Early Alzheimers Disease
Awaiting data
ADAG · Dec 2027 (est.)
ADG106: HER2-negative Breast Cancer
Awaiting dataupdated 11mo ago
TLX · Dec 2027 (est.)
177Lu-TLX591: Metastatic Castration-resistant Prostate Cancer
TAK · Dec 2027 (est.)
Tislelizumab: Minimal Residual Disease
SMMT · Dec 2027 (est.)
Ivonescimab: Extensive Stage Lung Small Cell Cancer
GOSS · Dec 2027 (est.)
Seralutinib: Pulmonary Arterial Hypertension
Awaiting data
INTS · Dec 2027 (est.)
INT230-6: Sarcoma,Soft Tissue
Awaiting dataupdated 11mo ago
LEGN · Dec 2027 (est.)
LCAR-B38M CAR-T Cell: Gastric Cancer
Awaiting dataupdated 7mo ago
LLY · Dec 2027 (est.)
Mirikizumab: Crohn's Disease
NUVL · Dec 2027 (est.)
Neladalkib: Locally Advanced Solid Tumor
OTLK · Dec 2027 (est.)
bevacizumab: Age-Related Macular Degeneration
Awaiting data
PCVX · Dec 2027 (est.)
31-valent pneumococcal conjugate vaccine: Pneumococcal Vaccines
Awaiting data
Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).